In the race to bring new oncology therapies to market, patient selection is more critical than ever. With narrow windows of exclusivity and mounting competitive pressure, biotech sponsors are rethinking their clinical development strategies -starting with smarter trial enrollment.  This live panel discussion featuring Dr. Brian Barnett and other leading industry experts will explore how […] The post Advancing Patient Selection in Oncology: Enrichment Strategies and Emerging Diagnostics appeared